Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status

Gut
Mingyang SongShuji Ogino

Abstract

Evidence suggests protective effects of vitamin D and antitumour immunity on colorectal cancer risk. Immune cells in tumour microenvironment can convert 25-hydroxyvitamin D [25(OH)D] to bioactive 1α,25-dihydroxyvitamin D3, which influences neoplastic and immune cells as an autocrine and paracrine factor. Thus, we hypothesised that the inverse association between vitamin D and colorectal cancer risk might be stronger for cancers with high-level immune response than those with low-level immune response. We designed a nested case-control study (318 rectal and colon carcinoma cases and 624 matched controls) within the Nurses' Health Study and Health Professionals Follow-up Study using molecular pathological epidemiology database. Multivariable conditional logistic regression was used to assess the association of plasma 25(OH)D with tumour subtypes according to the degree of lymphocytic reaction, tumour-infiltrating T cells (CD3+, CD8+, CD45RO+ (PTPRC) and FOXP3+ cells), microsatellite instability or CpG island methylator phenotype. The association of plasma 25(OH)D with colorectal carcinoma differed by the degree of intratumoural periglandular reaction (p for heterogeneity=0.001); high 25(OH)D was associated with lower risk of tumo...Continue Reading

References

Feb 13, 2001·The American Journal of Pathology·J AlexanderS R Hamilton
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BoonstraA O'Garra
Feb 17, 2006·The New England Journal of Medicine·Jean Wactawski-WendeUNKNOWN Women's Health Initiative Investigators
May 25, 2007·The New England Journal of Medicine·Andrew T ChanCharles S Fuchs
Jul 12, 2007·Journal of the National Cancer Institute·Kana WuEdward L Giovannucci
Jan 24, 2008·Nature Clinical Practice. Endocrinology & Metabolism·John S Adams, Martin Hewison
Oct 15, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuji OginoCharles S Fuchs
Mar 9, 2010·Nature Immunology·Marina Rode von EssenCarsten Geisler
Dec 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kristina EdfeldtRobert L Modlin
Jan 18, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anna M DahlinRichard Palmqvist
Aug 10, 2011·Nature Reviews. Clinical Oncology·Shuji OginoGlenn Dranoff
Aug 31, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yanlei MaHuanlong Qin
Oct 20, 2011·Genome Research·Aleksandar D KosticMatthew Meyerson
Nov 8, 2011·Biochimica Et Biophysica Acta·Laura A E HughesManon van Engeland
Jan 25, 2012·Nature Medicine·Dianren XiaRaymond N DuBois
Mar 16, 2012·Nature Reviews. Cancer·Wolf Herman FridmanJérôme Galon
Apr 7, 2012·Annals of Epidemiology·Jill Koshiol, Shih-Wen Lin
Sep 26, 2012·Nature Reviews. Immunology·Marc Veldhoen, Verena Brucklacher-Waldert
Oct 5, 2012·Journal of Translational Medicine·Jérôme GalonBernard A Fox
Oct 26, 2012·The New England Journal of Medicine·Xiaoyun LiaoShuji Ogino
Jan 25, 2013·World Journal of Gastroenterology : WJG·Fabio GrizziLuigi Laghi
Aug 7, 2013·Cancer Prevention Research·Edmond MarzbaniMary L Disis
Aug 24, 2013·International Journal of Molecular Sciences·Dora ColussiLuigi Ricciardiello
Sep 21, 2013·Nature Immunology·Thomas F GajewskiYang-Xin Fu
Oct 15, 2013·The Journal of Pathology·Jérôme GalonFranck Pagès
Oct 16, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michael HoffmeisterHermann Brenner
Oct 25, 2013·Journal of Cellular and Molecular Medicine·Giuseppe Di CaroFabio Grizzi
Dec 10, 2013·Journal of the National Cancer Institute·Jiyoung AhnLiying Yang
Apr 8, 2014·Nature Reviews. Cancer·David FeldmanBrian J Feldman
Jun 19, 2014·Cancer Research·Stacey MeekerLillian Maggio-Price
Jul 24, 2014·Cancer Causes & Control : CCC·Bo ZhouYingying Xing
Oct 4, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Meira EppleinPeter A Kanetsky
Dec 5, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Peter T CampbellSusan M Gapstur

❮ Previous
Next ❯

Citations

Dec 5, 2015·Expert Review of Molecular Diagnostics·Akihiro NishiShuji Ogino
Apr 3, 2016·International Journal of Cancer. Journal International Du Cancer·Akiko HanyudaYin Cao
Jan 31, 2017·International Journal of Environmental Research and Public Health·Cem EkmekciogluMichael Kundi
Mar 23, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A FuchsK Ng
Mar 23, 2017·Critical Reviews in Oncology/hematology·Michael J DuffyJohn Crown
Jul 20, 2017·Nature Immunology·Laurence ZitvogelGuido Kroemer
May 15, 2018·The Laryngoscope·Eva B YokosawaAlison M Mondul
Oct 28, 2015·Mediators of Inflammation·Corina-Daniela EneIlinca Nicolae
Dec 22, 2017·European Journal of Epidemiology·Li LiuShuji Ogino
Jul 7, 2015·Analytical Cellular Pathology (Amsterdam)·Akash M MehtaEkaterina S Jordanova
May 17, 2017·European Journal of Epidemiology·Akiko HanyudaReiko Nishihara
Feb 26, 2019·Cancer Causes & Control : CCC·Johanna E TorfadottirLaufey Steingrimsdottir
Oct 9, 2015·European Journal of Epidemiology·Reiko NishiharaShuji Ogino
Jun 26, 2020·Frontiers in Oncology·Robert PowerMargaret R Dunne
Jul 1, 2017·Clinical and Translational Gastroenterology·Jun Sun
Aug 13, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·E ShawN T Brockton
Apr 3, 2019·British Journal of Cancer·Jakob Nikolas Kather, Niels Halama
Aug 4, 2018·European Journal of Epidemiology·Stephanie J WeinsteinDemetrius Albanes
May 10, 2017·Epidemiologic Reviews·Alison M MondulDemetrius Albanes
Jan 18, 2017·Cancer Causes & Control : CCC·Peter T CampbellShuji Ogino
Nov 12, 2020·Cancer Communications·Zhenye TangJinfang Zhang
Oct 1, 2015·Cancer Immunology Research·Kosuke MimaShuji Ogino
Feb 15, 2019·Cancer Prevention Research·Wanshui YangXuehong Zhang
Sep 25, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chen YuanKimmie Ng
Oct 28, 2019·Molecular Therapy Oncolytics·Xiaoming ZhongZhiwen Yang
Nov 7, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Nazanin FathiSimin Sharifi
May 1, 2021·Frontiers in Cell and Developmental Biology·Xinyue YuGuanghui Cheng
Dec 4, 2021·Gut·Chen DongJames Cheng-Chung Wei

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Mingyang SongEdward L Giovannucci
International Journal of Cancer. Journal International Du Cancer
Angela K GreenRulla M Tamimi
© 2022 Meta ULC. All rights reserved